PatternsRadar
Sign in

LUPINLupin Limited

NSEF&O
Full chart
2,029.30INR+18.30 (+0.91%)Close · 6 Oct 2026
6 Aug 2026Last results
HealthcareSector
Pharmaceuticals & BiotechnologyIndustry
₹92,798 CrMarket cap
16.7P/E (TTM)
69.2%Delivery

Filings & corporate actions

81 results filed
CSV
Next results · Q2 FY27
Expected 28 Oct 2026 – 10 Nov 2026
Estimate: filed 28–41 days after quarter end, last 5 times
Dividend
₹18.00 per share · last 17 Jul 2026
2026
  • 6 AugresultsResults · Q1 FY27 · consolidated and standalone-0.9%NSE
  • 21 JulshareholdingShareholding · 30 Jun 2026+1.5%NSE
  • 17 JuldividendDividend · ₹18.00 per share-2.3%
  • 8 MayresultsResults · Q4 FY26 · standalone-3.3%NSE
  • 7 MayresultsResults · Q4 FY26 · consolidated-3.3%NSE
  • 20 AprshareholdingShareholding · 31 Mar 2026+0.1%NSE
  • 12 FebresultsResults · Q3 FY26 · consolidated and standalone-0.5%NSE
  • 20 JanshareholdingShareholding · 31 Dec 2025-0.4%NSE

Reaction to results · all yearsrose on day 0 in 33 of 78 CSV

QuarterFiledDay 0+5D+20DRel vol
Q1 FY276 Aug 2026-0.9%-6.3%-11.5%2.2×
Q4 FY267 May 2026-3.3%-7.5%-8.4%2.6×
Q3 FY2612 Feb 2026-0.5%+0.4%+3.6%1.4×
Q2 FY266 Nov 2025+0.8%+5.1%+7.3%4.1×
Q1 FY265 Aug 2025-0.7%+6.7%+4.3%2.8×
Q4 FY2514 May 2025+0.1%-5.0%-2.3%2.0×
Q3 FY2512 Feb 2025-2.1%-4.3%-4.8%3.1×
Q2 FY257 Nov 2024-0.3%-3.6%+1.1%3.8×
Q1 FY256 Aug 2024+4.4%+8.5%+19.9%4.7×
Q4 FY247 May 2024-4.1%-2.5%-6.8%4.9×
Q3 FY247 Feb 2024+0.8%+0.7%+4.5%6.6×
Q2 FY249 Nov 2023-0.5%-1.4%+2.3%3.8×
Q1 FY243 Aug 2023+2.8%+4.0%+6.0%4.7×
Q4 FY2310 May 2023+0.6%+4.7%+9.7%4.1×
Q3 FY239 Feb 2023-4.8%-13.4%-15.5%4.9×
Q2 FY2310 Nov 2022+3.6%+6.0%+8.7%13.8×
Q1 FY234 Aug 2022+5.2%+8.8%+4.0%15.3×
Q4 FY2219 May 2022-7.1%-12.1%-11.8%8.0×
Q3 FY224 Feb 2022-3.1%-11.3%-22.1%6.4×
Q2 FY2228 Oct 2021+4.7%+5.4%+0.3%5.4×
Q1 FY2210 Aug 2021-6.2%-13.1%-12.3%5.7×
Q4 FY2113 May 2021-2.8%+0.2%+1.5%1.2×
Q3 FY2129 Jan 2021-4.0%+2.0%-3.0%1.8×
Q2 FY215 Nov 2020-0.9%-5.2%+2.4%1.7×
Q1 FY217 Aug 2020-6.0%+8.8%+0.9%4.7×
Q4 FY2029 May 2020-2.3%+3.5%+6.3%1.4×
Q3 FY206 Feb 2020-2.0%-0.6%-9.8%4.7×
Q2 FY206 Nov 2019-4.4%-3.8%-1.2%4.2×
Q1 FY207 Aug 2019-2.7%-6.4%-2.9%2.4×
Q4 FY1916 May 2019+0.1%-4.1%-7.5%5.7×
Q3 FY1912 Feb 2019-2.4%-6.0%-5.8%1.5×
Q2 FY1921 Nov 2018+0.1%+4.4%+1.0%0.6×
Q1 FY1924 Aug 2018+0.4%+3.1%-2.3%0.9×
Q4 FY1826 May 2018+4.9%+3.8%+22.5%1.7×
Q3 FY181 Mar 2018-1.7%-4.2%-3.6%1.1×
Q2 FY181 Nov 20170.0%-18.2%-18.8%0.4×
Q1 FY1821 Aug 2017-1.6%+5.4%+7.1%0.5×
Q4 FY1712 Jun 2017+1.7%-4.1%-1.7%0.5×
Q3 FY1710 Feb 2017-1.7%-2.2%-3.0%1.6×
Q2 FY1710 Nov 2016-2.3%-7.3%-1.2%2.3×
Q1 FY174 Oct 2016+0.3%-1.6%-4.5%0.4×
Q4 FY1620 May 2016-9.1%-10.6%-11.6%4.9×
Q3 FY168 Feb 2016+1.0%-0.2%+1.2%1.6×
Q2 FY1629 Oct 2015+0.5%-3.8%-6.5%1.0×
Q1 FY1627 Jul 2015-3.3%-0.5%+7.9%2.6×
Q4 FY1521 May 2015+1.5%+7.3%+6.3%0.7×
Q3 FY157 Feb 2015-1.4%+6.0%+21.1%0.6×
Q2 FY1530 Oct 2014+1.8%+6.3%+9.9%1.0×
Q1 FY151 Aug 2014-1.4%-1.8%+10.7%1.3×
Q4 FY1412 May 2014+0.6%-3.0%+1.8%0.8×
Q3 FY145 Feb 2014+0.4%-0.2%+7.8%0.7×
Q2 FY1415 Nov 2013-0.4%-1.9%+0.9%0.9×
Q1 FY1412 Aug 2013+2.3%-6.3%+5.6%0.6×
Q4 FY139 May 2013+2.3%+11.2%+3.8%1.4×
Q3 FY1331 Jan 2013+0.8%-0.7%-2.4%3.4×
Q2 FY1323 Oct 2012-1.2%-0.6%-0.9%1.3×
Q1 FY1324 Jul 2012+2.0%+5.4%+1.4%3.6×
Q4 FY1210 May 2012-1.4%+2.6%+4.4%1.7×
Q3 FY1224 Jan 2012+2.1%+9.3%+9.3%1.5×
Q2 FY129 Nov 2011-1.3%-7.1%-8.2%1.8×
Q1 FY1227 Jul 2011+0.1%+2.3%+1.0%1.7×
Q4 FY1112 May 2011+0.9%+5.7%+4.4%2.5×
Q3 FY1128 Jan 2011-5.1%-4.3%-15.4%5.1×
Q2 FY111 Nov 2010+1.4%+2.2%+16.7%1.1×
Q1 FY1128 Jul 2010-1.4%-1.8%-2.9%2.7×
Q4 FY105 May 2010-0.1%-1.0%+1.4%4.8×
Q3 FY1029 Jan 2010+1.3%+9.4%+6.9%1.2×
Q2 FY1026 Oct 2009-1.2%-1.9%+6.8%1.4×
Q1 FY1029 Jul 2009-0.6%-1.0%+9.4%1.5×
Q4 FY0914 May 2009-4.3%+12.0%+11.3%6.1×
Q3 FY0929 Jan 2009-0.2%+4.4%+15.4%4.3×
Q2 FY0924 Oct 2008-1.5%+12.2%-13.8%1.5×
Q1 FY0922 Jul 2008+4.0%+2.9%+5.7%4.7×
Q4 FY0814 May 2008+3.0%+18.1%+28.4%4.1×
Q3 FY0822 Jan 2008-6.6%-3.9%+0.9%2.4×
Q2 FY0824 Oct 2007+5.6%-0.9%-8.5%1.4×
Q1 FY0819 Jul 2007-1.9%-8.8%-16.5%3.2×
Q4 FY079 May 2007-1.7%-1.6%-2.4%1.7×
Average-0.6%-0.1%+0.8%

Close-to-close from the session before the filing could trade. Day 0 is the first session after it.

Growth · Q1 FY27

CSV
Revenue YoY+32.0%
Profit YoY+16.0%
Interest cost YoY—
Revenue QoQ+10.7%
Profit QoQ-3.5%
CAGR2Y3Y4Y5Y6Y7Y
Revenue——————
Profit——————

Key data

CSV
Open2,011.00
Day range2,003.00 – 2,031.40
52-week range1,900.00 – 2,529.50
From 52w high-19.8%
RSI (14)34.1
ATR (14)39.21
Volume10.66L
Avg volume (20D)7.07L
Rel volume1.51×
Volatility (1Y)19.6%
Turnover₹216.4Cr
SMA 50 / 2002,193.05 / 2,256.20

Delivery percentage

Latest · 6 Oct 202669.2%
20-day avg59.1%
1-year avg57.6%
Percentile (own history)97th
Range5.2–87.5%
Sessions1,731

Over the last 20 sessions LUPIN settled 59.1% of its traded quantity, which is above average for an NSE equity. That is in line with its own one-year average of 57.6%. The latest session ranks higher than 97% of the 1,731 sessions on record for it.

What delivery percentage measuresScan the whole market on delivery

IndustryPharmaceuticals
PeersDIVISLABLAURUSLABSSUNPHARMAWOCKPHARMADRREDDYMOREPENLAB

Performance returns

CSV
1D1W1M3M6M1Y
Price+0.91%-1.59%-4.82%-18.51%-10.78%+5.70%

Valuation

CSV
Market cap₹92,798 Cr
P/E (TTM)16.7
EPS (TTM)121.39
Shares outstanding45.73Cr
Listed10 Sept 2001

Ownership

CSV
Promoter46.85%
Promoter Δ QoQ-0.01 pp
Public53.15%
FII22.42%
DII24.65%
Pledged0.00%

Quarterly results · consolidated

CSV
Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Revenue (₹ Cr)7,047.57,167.57,474.78,276.9
YoY chg——+31.9%+32.0%
Net profit (₹ Cr)1,484.81,180.51,468.71,417.0
YoY chg——+87.7%+16.0%
Net margin21.1%16.5%19.6%17.1%
EPS32.2825.6731.8930.89

Shareholding over time

CSV

By quarter

30 Jun 2026 · promoter 46.85% · public 53.15%
30 Sept 2021: promoter 46.83%31 Dec 2021: promoter 46.81%31 Mar 2022: promoter 46.78%30 Jun 2022: promoter 47.10%30 Sept 2022: promoter 47.11%31 Dec 2022: promoter 47.10%31 Mar 2023: promoter 47.08%30 Jun 2023: promoter 47.07%30 Sept 2023: promoter 47.06%31 Dec 2023: promoter 47.04%31 Mar 2024: promoter 47.01%30 Jun 2024: promoter 46.98%30 Sept 2024: promoter 46.96%31 Dec 2024: promoter 46.95%31 Mar 2025: promoter 46.92%30 Jun 2025: promoter 46.90%30 Sept 2025: promoter 46.90%31 Dec 2025: promoter 46.89%31 Mar 2026: promoter 46.86%30 Jun 2026: promoter 46.85%
2021-092026-06
  • Promoter
  • Public and others
Promoter
46.85%
Public
53.15%
Promoter change
-0.01 pp
Filed
21 Jul 2026
FII
22.42%
DII
24.65%
Promoter pledged
0.00%

Promoter and public shares of total equity, from the pattern filed each quarter. Institutional and pledge figures come from a separate filing stage whose backfill is still running, so they are absent for almost every instrument rather than zero.

Financials · quarterly statement

CSV
₹ crore, as filed
 Q2 FY24Q3 FY24Q4 FY24AQ1 FY25Q2 FY25Q3 FY25Q4 FY25AQ1 FY26Q2 FY26Q3 FY26Q4 FY26AQ1 FY27
Revenue from operations5,038.65,197.44,960.85,600.35,672.75,767.75,667.16,268.37,047.57,167.57,474.78,276.9
Other income40.429.429.367.842.353.757.079.090.0114.7140.7130.3
Total income5,079.05,226.84,990.05,668.15,715.05,821.45,724.16,347.47,137.57,282.27,615.48,407.2
Total expenses4,449.34,490.74,492.34,675.14,660.24,750.24,828.24,931.85,130.55,333.65,556.06,389.8
└ Finance costs80.674.071.368.070.966.989.191.8107.6115.0120.2109.6
└ Depreciation247.9257.2457.1247.7256.9271.5393.2299.0316.8313.0446.8452.9
Profit before tax629.7736.1497.7993.01,054.91,071.3895.81,415.52,007.01,522.01,928.02,017.4
Tax expense134.4117.4129.5187.5195.4212.4113.5194.1522.1341.5459.3600.4
Net profit495.3618.7368.2805.5859.5858.9782.41,221.51,484.81,180.51,468.71,417.0
EPS10.7613.477.8917.5818.7018.7516.9326.7032.3625.7431.9630.95
Net margin9.83%11.90%7.42%14.38%15.15%14.89%13.81%19.49%21.07%16.47%19.65%17.12%
PBT margin12.50%14.16%10.03%17.73%18.60%18.57%15.81%22.58%28.48%21.24%25.79%24.37%
Tax rate21.34%15.95%26.02%18.88%18.52%19.83%12.67%13.71%26.02%22.44%23.82%29.76%

A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. A quarterly filing carries a profit and loss only — there is no balance sheet behind it, and so no debt, cash flow or return-on-capital figure here. Latest filed 6 Aug 2026.

LUPIN at a glance

  • LUPIN closed at ₹2,029.3 on 6 Oct 2026, +0.91% on the day, +5.7% over one year, 19.8% below its 52-week high of ₹2,529.5.
  • Delivery was 69.2% of traded quantity on 6 Oct 2026, the 97th percentile of its own 1,731 sessions with a reading (20-session average 59.1%, 1-year average 57.6%).
  • Market capitalisation is ₹92,798 crore at a trailing P/E of 16.7 (trailing EPS ₹121.39).
  • Q1 FY27 results (consolidated, filed 6 Aug 2026): revenue ₹8,277 crore (+32.0% year on year), net profit ₹1,417 crore (+16.0%); the price moved -0.9% on the first session after.
  • Promoters held 46.85% at 30 Jun 2026, down 0.01 percentage points on the previous filing.
  • Q2 FY27 results are expected between 28 Oct 2026 and 10 Nov 2026, going by past filing dates — an estimate, not an announcement.

About

CSV
Macro sectorHealthcare
Basic industryPharmaceuticals
ISININE326A01037
SeriesEQ
Listed10 Sept 2001
History from10 Sept 2001
Sessions6,227
Turnover rank#212

Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 6 Oct 2026.

More in Pharmaceuticals & Biotechnology

CSV

All Pharmaceuticals & Biotechnology stocks on the NSEAll Healthcare stocks on the NSE